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Abstract 
Background: Asthma, the most common chronic disease in childhood, is an inflammatory disease 
of the airways. The presence of chronic inflammation in the organism causes production of ROS;  
this suggests that asthma could be associated to an accelerated biological aging.  
Objective: To explore if there is an association between asthma in school-age children from the 
population-based birth cohort study HELIX (n = 1623) and three proposed aging markers: telomere 
length, mitochondrial DNA, and DNA methylation age.  
Methods: Information on wheezing and asthma was obtained from parental questionnaires 
administered at 6-11 years. We defined “active wheezing” as either by wheezing or by having 
taken medication in the last year and “asthma” as children ever diagnosed with asthma by a doctor. 
Leukocyte TL and mtDNA content were measured in the children at 6-11 years employing real 
time polymerase chain reaction (qPCR). DNAm was measured on blood samples using the 
Horvath (Illumina HumanMethylation27 Bead Chip) and Hannum (Illumina HumanMethylation 
450 BeadChip) algorithms.  
Results: Prevalence of active wheezing and asthma was 10% and 17%, respectively. Ever asthma 
was borderline statistically significantly associated with a decrease of 2.21% (95% CI: -
6.21%;1.94%) in mtDNA. mtDNA also decreased in children with active wheezing compared to 
children with no wheezing. Active wheezing was non-statistically significantly associated with an 
increase in HOma (0,20 (95% CI: -0,03;0,44) and HAma (0,28 (95% CI: -0.13;0.68), in relation 
to children without active wheezing. Ever asthma was non-statistically significantly associated 
with an increase in HAma compared with children without asthma. Associations did not 
substantially change after considering air pollution as confounder.  
Conclusion: This study, the first one to assess whether asthma is related to biological aging in 
children, finds little evidence of associations of active wheezing and ever asthma with three 
different biological ageing markers. Further studies are needed to confirm these results.  
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1. Introduction 
Asthma is an increasingly more common chronic inflammatory disease of the airways in 
both children and adults worldwide. ISAAC (The International Consensus Report on the Diagnosis 
and Treatment of Asthma) showed that the global prevalence increased from mid-1990s to mid-
2000s, also being seen to increase as population becomes urbanized (I. Asher & Pearce, 2014; 
Masoli, Fabian, Holt, & Beasley, 2004). The symptoms are usually related to airway obstruction 
and increased airway responsiveness to various stimuli provoking: “wheezing”, shortness of 
breath, chest tightness and coughing (I. Asher & Pearce, 2014). Asthma is worsened by a 
combination of genetic and environmental factors such as air pollution and tobacco smoke  (I. 
Asher & Pearce, 2014; Masoli et al., 2004; Sears et al., 2003). Individuals who suffer from asthma 
at early ages are more likely to suffer asthma in adulthood, whether it is by relapse or persistence 
(Masoli et al., 2004; Sears et al., 2003). In addition, childhood asthma is of particular concern since 
it can predispose to other health problems (i.e. repeated respiratory infections) and chronic 
illnesses as COPD throughout life.  
Asthma involves a variety of inflammatory cell types and pro-inflammatory mediators 
which can cause oxidative stress with the production of reactive oxygen species (ROS) (Liu et al., 
2009). ROS arising from an asthma chronic inflammation state cause molecular damage in 
signaling pathways, enzymatic functions, gene expression and other essential biological processes. 
Depending on the individuals coping mechanisms to this damage, patients show different reaction 
to treatment, severity and persistence of the disease (Jesenak, Zelieskova, & Babusikova, 2017). 
Asthma is a heterogeneous condition and many different phenotypes have been defined (Wenzel, 
2006). Indeed, asthma phenotype needs to be better understood based on the oxidative stress and 
inflammatory pathways. There is evidence (Jesenak et al., 2017) that individuals with persistent 
asthma may experience more profound molecular damage, but this is little understood, although 
crucial for the clinics to better understand the aetiology of asthma and subsequent comorbidities 
and persistence. Furthermore, the relation between a known chronic inflammatory disease that has 
a high prevalence in the population and its effect on the aging mechanisms has received little 
attention.  
Different markers have been found to measure accelerated ageing at the molecular level. 
Telomeres are DNA structures that, with the help of telomere specific proteins (telomerase), 
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protect the end of chromosomes and maintain integrity of the genome (Albrecht et al., 2014). Cell 
senescence involves shortening of telomeres since with every cell division the telomere is not fully 
replicated (Epel et al., 2004; Kyoh et al., 2013). This erosion can also be caused by environmental 
factors, especially exposure to ROS arising from chronic inflammatory diseases or tobacco smoke 
exposure. Telomere length (TL) determinants can also include heritability, sex (women have on 
average longer telomeres), ethnicity and socioeconomic status (Zhu, Belcher, & van der Harst, 
2011). TL has been widely studied as a marker for biological age in association with many health 
conditions, although not to our knowledge in the context of asthma and TL in children.  
Another biological aging marker proposed is mitochondrial DNA content. It is well known 
that mitochondria’s main function is to produce energy (ATP) for the cell through the respiratory 
chain (Wei, 2000). This organelle also fulfills functions of signaling transduction for cell 
proliferation, apoptosis, calcium storage and metabolism (Clemente et al., 2016). Mitochondria 
counts with its own set of DNA (mtDNA) that consists of 13 polypeptides related to activities of 
respiration and oxidative phosphorylation (Wei, 2000). Mitochondria are both the main source of 
ROS (normal by-product of oxidative phosphorylation) and the primary target of oxidative stress 
(especially mtDNA since it lacks protection that is present in nuclear DNA) (Clemente et al., 2016; 
Wei, 2000). Because of the conditions mentioned before, it is also used as a marker of biological 
age.  
More recently, DNA methylation (DNAm) of some genomic regions that can be hyper or 
hypo methylated during aging has been found to be a good biomarker for cell and tissue aging 
(Horvath, 2013). It is a score made from a combination of CpG sites related to genes involved in 
age related diseases such as Alzheimer’s disease, cancer, tissue degradation, DNA damage, and 
oxidative stress (Hannum et al., 2013). The difference between DNAm age and chronological age 
has been suggested as a marker of age acceleration and it can be caused by environmental (i.e. 
stress), disease (i.e. cancer) or inherited factors (Gao, Zhang, Breitling, & Brenner, 2016; Hannum 
et al., 2013; Horvath, 2013). A study done in children has shown that there are hypo methylated 
sites directly related to tobacco exposure and disease in children (Gao et al., 2016). Another wide 
association (EWAS) study in children searched for the relation between asthma and DNAm 
(Arathimos et al., 2017). This has opened the path for more studies that relate the mechanisms of 
disease associated with aging in children and perhaps suggest effects carried through adulthood.  
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Current research has focused on asthma and biological aging markers separately. Only 
recently, investigation on relation between biological age and asthma has been done in adults 
(Belsky et al., 2014) and the before mentioned EWAS study for children and asthma (Arathimos 
et al., 2017) offering a need to determine whether children are being affected by this association.  
2. Objective 
The present study aims to examine whether childhood asthma is associated with three 
different aging markers (TL, mtDNA, and DNAm) in a large birth-cohort study population with 
children between the ages of 6 and 11 years.  
3. Materials and Methods 
3.1 Study design and population 
The HELIX (Human Early Life Exposome) study is a collaborative project of six 
population-based birth cohorts in different European countries: United Kingdom (BiB: Born in 
Bradford), France (EDEN; Étude des Déterminants pré et postnatals du développement et de la 
santé de l’Enfant), Spain (INMA; Infancia y Medio Ambiente), Lithuania (KANC; Kaunus 
cohort), Norway (MoBa; Norwegian Mother and Child Cohort Study), and Greece (RHEA; 
Mother Child Cohort study in Crete).   
The six cohorts have in total a population comprising 31,472 mother child pairs, with data on 
environmental exposures, clinical outcomes, social factors, diet, etc. From this population, 
approximately 200 mother-child pairs were selected randomly from each cohort to produce a 
nested subcohort (HELIX) of n=1301 mother-child pairs with a new follow up at 6-11 years where 
clinical examination and biological samples were taken. Some cohorts then invited and examined 
322 further subjects making the subcohort population N=1623 (Vrijheid et al., 2014, Maitré, et al. 
in press). The study population was restricted to children with information on wheezing or asthma 
and TL, mtDNA, and DNAm. We defined two populations: one with information on 
wheezing/asthma and TL/mtDNA (n=1383) and a second one with wheezing/asthma and DNAm 
data (n=1186). Some missings were identified for confounders which are detailed in Figure 1.  
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Figure 1. Population flow chart.  
 
3.2 Sample collection 
The follow-up examination of the subcohort consisted of collecting new biological samples 
according to the planned omics analyses (6-11 years children). Eighteen mL of blood were 
collected at the end of the clinical examination of each child, ensuring approximately 3 hour 
fasting. Blood samples were collected using a butterfly vacuum clip and local anesthetic and 
processed into a variety of sample matrices for serum, plasma, whole blood for RNA extraction 
(Tempus tubes – Life Technologies Cat No: 4342792), red cells, and buffy coat for DNA 
extraction. After processing, these samples were frozen at -80°C under optimized and standardized 
procedures (Maitré, et al. in press; Vrijheid et al., 2014).  
3.3 Measurement of aging markers 
TL and mtDNA were attained in the Center for Environmental Sciences, Hasselt 
University, Diepenbeek, Belgium; DNAm was obtained in the Centre for Genomic Regulation 
(CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain 
 
No outcome information
TL n= 233
mtDNA n= 232
DNAmAge n=430
No exposure information
n=7
HELIX subcohort N=1623
Children with follow 
up information on 
asthma
n=1616
Children with 
outcome information
TL/MtDNA
n= 1383
Children with 
outcome information
DNA methylation 
age
n=1186
Regression models 
(accounting 
confounders 
missings)
n=1142
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Average relative TL was measured by a modified quantitative real-time PCR (qPCR) 
protocol as described previously (Cawthon, 2009). Telomere and single copy-gene reaction 
mixture and PCR cycles used were described elsewhere (Martens et al. 2016). All measurements 
were performed in triplicate on a 7900HT Fast Real-Time PCR System (Applied Biosystems) in a 
384-well format. In each run, a 6-point serial dilution of pooled DNA was run to assess PCR 
efficiency that ranged from 90% to 102%; as well as eight inter-run calibrators to account for the 
inter-run variability. Relative TLs were calculated using qBase software (Biogazelle, Zwijnaarde, 
Belgium). They were expressed as the ratio of telomere copy number to single-copy gene number 
(T/S). We achieved coefficients of variation (CV) within triplicates of the telomere runs, single-
copy gene runs, and T/S ratios of 0.84%, 0.43%, and 6.4%, respectively.  
Relative mtDNA content was measured by determining the ratio of two mitochondrial gene 
copy numbers (mitochondrial encoded NADH dehydrogenase subunit 1 (MT-ND1) and 
mitochondrial forward primer for nucleotide 3212 and reverse primer from nucleotide 3319 
(MTF3212/R3319)) to one single-copy nuclear control genes (acidic ribosomal phosphoprotein P0 
(RPLP0)) using real-time PCR. mtDNA and single copy-gene reaction mixture and PCR cycles 
used can be found elsewhere (Janssen et al., 2012, Clemente et al., 2016). All measurements were 
performed in triplicate on a 7900HT Fast Real-Time PCR System (Applied Biosystems) in a 384-
well format. On each run, a 6-point serial dilution of pooled DNA was run to assess PCR efficiency 
that ranged from 96% to 107% as well as eight inter-run calibrators to account for the inter-run 
variability. Relative mtDNA content (two mitochondrial gene copy numbers relative to single 
nuclear gene) was calculated using qBase software (Biogazelle, Zwijnaarde, Belgium). CV within 
duplicates was 0.72% for mitochondrial genes and 0.43% for the single-copy gene. These 
measures were summarized by only two variables in total.   
Methylation age acceleration variables were estimated using the Horvath (Horvath, 2013) 
and Hannum (Hannum et al., 2013) algorithms from DNA methylation data (blood DNA 
methylation quantified using 450K, Illumina).  
The Horvath method was developed using a dataset of roughly 4000 samples from 20 healthy      
tissues and cell types assembled using a combination of Illumina HumanMethylation27              
BeadChip (27K) and Illumina Human Methylation 450 Bead Chip (450K) 
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technology. The Horvath method uses 353 CpG sites which are common to both platforms. The 
Horvath method uses 353 CpG sites and the Hannum method uses 71 CpG sites to estimate age. 
More details can be found in https://labs.genetics.ucla.edu/horvath/dnamage/. Variables for 
methylation age had 2 measures: AAHOAdjCellCounts (HOma) and AAHAAdjCellCounts 
(HAma). These were measures of age acceleration adjusted for cell counts (residuals resulting 
from multivariate regression models that regress an estimate of DNA methylation age on 
chronological age and various blood immune cell counts). AAHOAdjCellCounts and 
AAHAAdjCellCounts correspond to age acceleration measures based on Horvath (2013) and 
Hannum (2013), respectively.  
3.4 Childhood wheezing and asthma 
Information on occurrence of wheezing and asthma was obtained through questionnaires 
adapted from the International Study on Asthma and Allergy in Childhood (ISAAC) filled by the 
parents at the time of follow up (6-11 years children) (M. I. Asher et al., 1995). Active wheezing 
wad defined as having had any episode of wheezing or had medication for asthma in the last year. 
Asthma was defined as asthma ever diagnosed by a doctor. 
3.5 Confounders 
Confounders considered for the statistical analyses were: child’s sex, child’s age at the time of the 
follow-up, socioeconomic status (maternal education, family affluence score (FAS), parity, child 
ethnicity, cohort center, child’s body mass index score (BMI in kg/m²-for-age-and-sex z-scores 
using the international World Health Organization (De Onis et al., 2007) reference curves in order 
to allow comparison with other studies, zBMI, birth weight in grams, tobacco smoke exposure 
during pregnancy (TSEp), current tobacco smoke exposure from parents smoking habit at age of 
follow up (TSEc), marital status, mother age at birth, parents asthma history, batch effect (only for 
TL), cell proportion (only for TL and mtDNA since methylation age markers were already adjusted 
for cell count) and concentrations of air pollutants (NO2, PM10, PM2.5).  
3.6 Statistical analysis  
3.6.1 Population description and confounders selection  
First, description of the populations was done according to the whole population N=1383 
and according to wheezing and asthma statuses. Bivariate analysis tests (Wilcoxon, Chi square, 
Student’s t-test, Kruskal-Wallis or correlation depending on variable characteristics) were carried 
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out to explore the associations between wheezing/asthma and biological aging markers with 
potential confounders. Confounders were selected based on a review of the literature on the 
determinants of childhood wheezing and asthma and biological aging makers (Belsky et al., 2014; 
Clark et al., 2010; Strachan & Cook, 1998). Secondly, we performed linear regression models 
between biological aging markers and chronological age of the children (6-11 years) adjusted for 
cohort. Third, we also tested the association across the three aging markers to see how they 
associate to each other using linear regression models adjusted to sex, cohort and cell count. 
3.6.2 Association between wheezing and asthma and biological aging markers 
The distribution of TL/mtDNA (both continuous) was checked and log10 transformed to reach 
normality. HOma and HAma variables were both normally distributed. Active wheezing and 
asthma were analyzed as predictors of accelerated aging response through the four biological 
markers separately. For each association (i.e. active wheezing and TL, active wheezing and 
mtDNA), four linear regression models were constructed considering the confounders associated 
with wheezing or asthma and at least one aging marker in the bivariate analyses. The four models 
were the following: 1) minimally adjusted model (sex, age, cohort), 2) moderately adjusted model 
(minimally adjusted model + zBMI, ethnicity, FAS, TSEp), 3) fully adjusted model (moderately 
adjusted model + cell count – only for TL and mtDNA), and 4) fully adjusted model + air pollution 
(fully adjusted model + NO2). Beta coefficient units for TL correspond to the ratio explained 
previously, in which a β under 1 corresponds to a shorter telomere and over 1 to a longer telomere. 
Similarly, for mtDNA, β under 1 corresponds to less quantity of mtDNA and over 1 more. Since 
TL and mtDNA were log10 transformed they were back transformed for interpretation as 
percentage using the formula ((10^(Beta))-1)*100 and ((10^(CI))-1)*100. All analyses were 
performed using the statistical package RStudio Version 1.1.423 – © 2009-2018 RStudio, Inc. 
http://www.r‐project.org). 
4. Results 
4.1 Characteristics of the study population 
Table 1 describes the characteristics of the study population of all children. For this 
description we focused on the large population, since distribution was similar for the smaller 
population subset. Children had a median age of 8.2 years (6.5-9.1), 635 (46%) were female, 
mainly of white European origin 1208 (87%). Median family affluence scale (FAS) showed 687 
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(50%) were from high income families with 624 (48%) of mothers with high education, 609 (47%) 
were first time mothers, 217 (17%) actively smoked during pregnancy and 427 (31%) were passive 
smokers during pregnancy; 545 (59%) of parents were active smokers at the age of follow up. 
Birth weight median was 3360g (3040-3670) and 1079 children (78%) were considered as normal 
weight at follow up evaluation.  
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Table 1. Population description. 
 
 
Missing 
% All 
 
Missing 
% All 
 
Missing 
% All 
N 
 
1383 
  
1383 
  
1383 
Child 
characteristics 
  
Family 
characteristics 
  
Other 
  
Sex, female % 0% 46% 
Family Affluence 
Score, % 
4 
(0.0%) 
 
Cell 
proportion, 
median (IQR) 
209 
(15.0%) 
 
Age (years), median 
(IQR) 0% 8,2 (6,5-9,1) Low 
 
11% NK 
 
0,016 (0-0,048) 
Body mass index, 
% 0% 
 
Middle 
 
39% Bcell 
 
0,109 (0,082-
0,138) 
Obese 
 
6% High 
 
50% CD4T 
 
0,19 (0,15-0,232) 
Overweight 
 
16% 
Maternal 
education, % 
90 
(6.5%) 
 
CD8T 
 
0,116 (0,086-
0,144) 
Underweight/Normal 
 
78% Low 
 
15% Eos 
 
0 (0-1,03e-18) 
zBMI, median 
(IQR) 
 
0,38 (-0,35-1,22) Middle 
 
33% Mono 
 
0,076 (0,059-
0,093) 
Birth weight (g), 
median (IQR) 59 (4%) 3360(3040 - 3670) High 
 
45% Neu 
 
0,463 (0,381-
0,543) 
Ethnicity, % 
2 
(0.001%) 
 
Parity, % 
79 
(6.0%) 
 
Air 
contaminants, 
median (IQR) 
4 
(0.0%) 
 
Other 
 
13% No child 
 
44% NO2 
 
807 (386 - 1214) 
White european 
 
87% One child 
 
34% PM 10 
 
828 (434 - 1210) 
Doctor diagnosed 
asthma, yes % 0% 10% More than one child 
 
16% PM
 2.5 
 
817 (396 - 1196) 
Active wheezing in 
the last year % 0% 17% Marital status % 
62 
(4.0%) 
    
TL, median (IQR) 0% 0,99(0,88-1,13) Living alone 
 
3% 
   
mtDNA, median 
(IQR) 0% 1,03(0,89-1,21) Living with father 
 
90% 
   
HOma, median 
(IQR) 0% -0,11(-0,97-0,85) Other 
 
2% 
   
HAma, median 
(IQR) 0% -0,08(-1,73-1,79) 
Mother age at 
birth, median 
(IQR) 
62 
(4.0%) 
31(27.5 - 
34) 
   
   
Tobacco smoke 
exposure during 
pregnancy % 
94 
(6.0%) 
    
   
No exposure 
 
47% 
   
   
Passive smoker 
 
31% 
   
   
Active smoker 
 
16% 
   
   
Parents smokers 
age 9 years, % 
16 
(1.0%) 
    
   
Yes 
 
59% 
   
   
Parents asthma % 3 (0.0%) 
    
   
Yes 
 
19% 
   
 
11 
 
4.2 Bivariate analysis  
Table 2 shows p-values of bivariate analyses between wheezing/asthma and biological 
aging markers with potential confounders. Shadowed in grey are those associations with 
significant p-values. Confounders that showed association with wheezing or asthma and at least 
one aging marker were: child’s sex, child’s age, zBMI, ethnicity, FAS, TSEp, blood cell count 
(eosinophils and Bcells), and NO2. mtDNA showed the most associations to confounders.  
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Table 2. Bivariate analysis  
 
Ever asthma No asthma  
Asthma 
(p-value) Wheezing  
No 
wheezing 
Wheezing  
(p-value) 
TL  
(p-value) 
mtDNA  
(p-value) 
HOma  
(p-value) 
HAma  
(p-value) 
N 144 1239 
 
241 1142 
 
1383 1383 1186 1186 
Child characteristics 
          
Sex, female % 35% 47% 0,006 37% 48% 0,002 0,000 0,575 0,045 0,008 
Age (years), median (IQR) 7,2(6,5-8,8) 8,2(6,5-9,1) 0,198 6,9(6,5-8,8) 8,3(6,6-9,2) 0,000 0,141 0,000 0,927 0,631 
Body mass index, % 
  
0,723 
  
0,029 0,298 0,176 0,434 0,234 
Obese 6% 6% 
 
10% 5% 
     
Overweight 18% 15% 
 
16% 16% 
     
Underweight/Normal 76% 78% 
 
74% 79% 
     
zBMI, median (IQR) 0,39(-0,27-1,4) 0,38(-0,35-1,21) 0,462 0,53(-0,27-1,44) 
0,35(-0,36-
1,2) 0,052 0,003 0,460 0,097 0,478 
Birth weight (g), median (IQR) 3420(3052 - 3750) 3360(3040 - 3660) 0,288 
3305(2992 - 
3670) 
3370(3050 
- 3670) 0,232 0,626 0,000 0,961 0,122 
Ethnicity, % 
  
0,043 
  
0,025 0,380 0,000 0,999 0,240 
Other 18% 12% 
 
17% 12% 
     
White European 81% 88% 
 
83% 88% 
     
Doctor diagnosed asthma, yes % 100% 0% - 43% 4% 0,000 0,578 0,047 0,569 0,424 
Active wheezing in the last year % 72% 11% 0,000 100% 0% - 0,952 0,001 0,104 0,304 
TL 0,98(0,88 - 1,11) 0,99(0,88-1,13) 0,578 0,98(0,89-1,13) 
0,99(0,88-
1,12) 0,952 - 0,005 - - 
mtDNA  0,99(0,86-1,19) 1,04(0,89-1,22) 0,047 1(0,857 - 1,16) 
1,04(0,9-
1,23) 0,001 0,005 - - - 
HOma, median (IQR) -0,02(-0,88 - 0,94) -0,12(-0,99 - 0,84) 0,000 0,13(-0,85-0,94) 
-0,14(-
1,03-0,80) 0,000 - - - 0,000 
HAma, median (IQR) 0,22(-1,54-2,15) -0,08(-1,74-1,77) 0,000 0,16(-1,65-1,95) 
-0,11(-
1,75-1,76) 0,000 - - 0,000 - 
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Family characteristics 
          
Family Affluence Score, % 
  
0,983 
  
0,001 0,182 0,000 0,357 0,729 
Low 11% 11% 
 
10% 11% 
     
Middle 40% 39% 
 
49% 37% 
     
High 49% 50% 
 
40% 52% 
     
Maternal education, % 
  
0,761 
  
0,304 0,552 0,000 0,045 0,351 
Low 17% 15% 
 
16% 15% 
     
Middle 32% 33% 
 
37% 32% 
     
High 44% 45% 
 
41% 46% 
     
Parity, % 
  
0,805 
  
0,190 0,049 0,144 0,755 0,937 
No child 44% 44% 
 
42% 44% 
     
One child 33% 34% 
 
32% 35% 
     
More than one child 18% 16% 
 
20% 15% 
     
Marital status, % 97,92% 95% 0,155 
  
0,110 0,017 0,000 0,283 0,256 
Living alone 1,39% 3% 
 
2% 3% 
     
Living with father 92,36% 90% 
 
90% 90% 
     
Other 4,17% 2% 
 
4% 2% 
     
Mother age at birth, median, IQR 30,5(26,5-33,5) 31(27,7-34,1) 0,061 30,7(27-34,2) 31(27,8-34) 0,297 0,001 0,097 0,871 0,411 
Tobacco smoke exposure during pregnancy, % 
  
0,043 
  
0,019 0,224 0,003 0,009 0,025 
No exposure 56% 46% 
 
41% 48% 
     
Passive smoker 23% 32% 
 
39% 29% 
     
Active smoker 16% 16% 
 
14% 16% 
     
Parents smokers age 9 years, % 
  
0,526 
  
0,091 0,040 0,016 0,216 0,312 
Yes 37% 40% 
 
44% 38% 
     
Parents asthma, % 
  
0,000 
  
0,000 0,458 0,208 0,885 0,875 
Yes 44% 16% 
 
30% 17% 
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 Ever asthma No asthma  
Asthma 
(p-value) Wheezing  No wheezing 
Wheezing  
(p-value) 
TL  
(p-value) 
mtDNA  
(p-value) 
HOma  
(p-value) 
HAma  
(p-value) 
Other           
Cell proportion, median, IQR           
NK 0,009(0-0,047) 0,017(0-0,049) 0,146 0,012(0-0,045) 0,017(0-0,049) 0,173 0,034 0,000 - - 
Bcell 0,113(0,085-0,141) 0,108(0,081-0,137) 0,061 0,114(0,085-0,142) 0,107(0,0811-0,137) 0,033 0,000 0,000 - - 
CD4T 0,198(0,16-0,238) 0,189(0,148-0,23) 0,078 0,187(0,157 - 0,233) 0,19(0,149-0,231) 0,630 0,000 0,000 - - 
CD8T 0,11(0,078-0,145) 0,116(0,087-0,144) 0,401 0,117(0,090-0,146) 0,115(0,086-0,144) 0,603 0,000 0,000 - - 
Eos 6,12e-20(0-2,58e-18) 0(0-8,25e-19) 0,000 0(0-2,5e-18) 0(0-7,41e-19) 0,000 0,187 0,063 - - 
Mono 0,073(0,057-0,088) 0,076(0,059-0,093) 0,085 0,075(0,056-0,089) 0,076(0,060-0,093) 0,170 0,286 0,931 - - 
Neu 0,456(0,375-0,541) 0,463(0,383-0,543) 0,369 0,459(0,376-0,55) 0,463(0,383-0,543) 0,524 0,000 0,000 - - 
Air contaminants, median, IQR           
NO2 734(302 - 998) 819(394 - 1236) 0,010 861(374 - 1224) 788(388 - 1214) 0,531 0,569 0,001 0,480 0,218 
PM10 648(371 - 1270) 841(454 - 1204) 0,258 900(483 - 1245) 814(420 - 1198) 0,083 0,916 0,036 0,468 0,424 
PM2.5 890(556 - 1190) 803(386 - 1198) 0,168 774(376 - 1089) 824(398 - 1219) 0,126 0,816 0,000 0,161 0,925 
Tests carried out according to variable characteristics: Chi square, Wilcoxon, Kruskal, Correlation, T student test.   
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4.3 Association between active wheezing and ever asthma and biological aging markers 
Table 3 shows the results of the linear regression models associating wheezing and asthma 
with each aging biomarker adjusting for confounders selected from the bivariate analysis.  
Ever asthma was borderline statistically significantly associated with a decrease of 2,21% 
(95% CI: -6,21%;1,94%) in mtDNA content, compared to children without asthma. This 
association became stronger but still non-significant when adjusting by cell count (-3,03% (95% 
CI: -6,47%;0,54%)) and did not substantially change after including NO2 into the model (-2,89% 
(95% CI: -6,34%;0,69%)). mtDNA also decreased in children with active wheezing compared to 
children with no wheezing (Fully adjusted model: -1,36% reduction; 95% CI: -4,30%;1,66%).  
Active wheezing was non-statistically significantly associated with an increase in HOma (0,20 
(95% CI: -0,03;0,44) and HAma (0,28 (95% CI: -0.13;0.68), in relation to children without active 
wheezing. These associations remained stable after considering air pollution. Ever asthma was 
non-statistically significantly associated with an increase in HAma (0,18 (95% CI: -0,30;0,67)), 
compared with children without asthma. 
No associations were observed between active wheezing/ever asthma and any of the biological 
aging markers. 
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Table 3. Adjusted regression models for asthma phenotype and biological aging markers. 
 
N=1142 
 
Biological aging marker 
Minimally adjusted* Moderately adjusted** Fully adjusted*** Fully adjusted + NO2**** 
β 95% CI β 95% CI β 95% CI β 95% CI 
TL 
Active wheezing 1,16% -1,59% 3,99% 1,35% -1,40% 4,17% 1,51% -1,25% 4,34% 1,51% -1,25% 4,34% 
Diagnosed asthma 0,14% -3,11% 3,51% 0,44% -2,81% 3,80% 0,24% -3,01% 3,60% 0,28% -2,97% 3,65% 
mtDNA 
Active wheezing -1,81% -5,17% 1,66% -1,48% -4,87% 2,02% -1,36% -4,30% 1,66% -1,37% -4,30% 1,66% 
Diagnosed asthma -2,21% -6,20% 1,94% -1,92% -5,93% 2,26% -3,03% -6,47% 0,54% -2,89% -6,34% 0,69% 
HOma Not applicable  
Active wheezing 0,17 -0,06 0,40 0,20 -0,03 0,44 
 
0,20 -0,03 0,44 
Diagnosed asthma 0,10 -0,17 0,37 0,09 -0,19 0,37 0,09 -0,19 0,37 
HAma Not applicable  
Active wheezing 0,24 -0,16 0,64 0,28 -0,13 0,68 
 
0,27 -0,13 0,68 
Diagnosed asthma 0,21 -0,27 0,69 0,18 -0,30 0,67 0,20 -0,28 0,69 
*Adjusted for age, sex, and cohort, **Adjusted for age, sex, cohort,,zBMI, ethnicity, FAS, and TSEp, ***Adjusted for age, sex, cohort,zBMI, 
ethnicity, FAS, TSEp, and cell count (only for TL and mtDNA), ****Adjusted for age, sex, cohort,,zBMI, ethnicity, FAS, TSEp, cell count (only for 
TL and mtDNA), and NO2. 
5. Discussion 
In this study, based on six European countries, we observed a borderline inverse association 
between ever asthma and mtDNA. We also observed that active wheezing was associated with an 
increase in HOma and HAma, although associations did not reach statistical significance. Neither 
active wheezing nor ever asthma were associated with TL.  
To our knowledge, only one study has previously assessed the relationship between asthma 
and biological aging markers and it was conducted in adults (Belsky et al., 2014). In this study, a 
two time point analysis of TL in a population of n=1037 individuals that were sought for asthma 
at 9 assessments spanning 9-38 years was carried out. They observed that adults with life-course-
persistent asthma had shorter TL (β = 20.31; P < 0.001) than those with no reported asthma, and 
this association was attenuated when adjustment for eosinophils was performed (Belsky et al., 
2014). No changes in TL were observed in adults with childhood and adolescent/adult onset 
asthma. In this study TL was the only aging marker considered. Our study, in contrast, includes 
TL and two more biological aging markers. This allowed a better understanding of the role asthma 
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plays on the organism at the molecular level in particular in inflammatory cells. The effect caused 
by higher eosinophils seen by Belsky, et al. could not be assessed in our study since no association 
between asthma and TL was shown. Nonetheless, in our study eosinophils were also seen to be 
slightly higher in asthma diagnosed children. Some of the children in our study might have 
adolescent onset of asthma, showing importance of following studies in the population to add to 
the understanding of persistence effect of the disease on molecular levels. Perhaps, children with 
asthma in our study might need more time to show noticeable molecular changes on aging markers. 
It is therefore important to do follow up studies in children that participated in HELIX during 
adolescence and adulthood so that changes in biological aging markers can be identified. It was 
also seen by another study that age at onset was related to persistence in adulthood which 
contributes to the importance of including age of diagnosis and beginning of symptoms in the 
analysis (Sears et al., 2003). This will contribute to a better understanding of the effect of persistent 
asthma at molecular levels and also the asthma phenotype which can also follow different 
inflammatory cell association and not just an eosinophilic pattern, but also neutrophilic or pauci-
granulocytic (Wenzel, 2006). 
DNA methylation studies have shown association between asthma/wheezing and DNA 
methylation sites in children, but when the authors adjusted for cell count all associations were 
lost, showing also a high influence of eosinophils and neutrophils on the results (Arathimos et al., 
2017). It was suggested that asthma phenotype may be better defined in subtypes according to their 
eosinophils and neutrophils status (Wenzel, 2006).  
The main strengths of this study are the large sample size and the availability of three 
different biological aging markers. We also could adjust our models for cell counts and air 
pollution, which is one of the most potential confounders of the association of asthma-related 
symptoms and biological aging markers. Our study however, has some limitations: a lack in ethnic 
diversity, as 87% of children were from white European origin, un-inclusion of dietary elements 
that could influence oxidative stress by intake of antioxidants that could help as coping 
mechanisms and a simple definition of asthma that did not include other important factors as 
repeated infectious respiratory diseases and time of diagnosis or onset of symptoms that would 
indicate persistence. Adding to this, first, wheezing and asthma were self-reported and therefore 
outcome misclassification cannot be ruled out due to under- or over-reporting of wheezing and 
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asthma. This may have led to either attenuation or overestimation of the effect estimates. Second, 
it is important to consider that mtDNA showed a high sensitivity to external factors and that causes 
difficulty to analyze the effect caused by asthma. Finally, since data on wheezing and asthma was 
collected at the same time as aging markers determination, reverse causation cannot be ruled out 
(i.e. if shorter TL predisposes the organism to suffer from asthma or if asthma is shortening TL).  
6. Conclusion 
Childhood asthma is an increasingly prevalent disease that affects the quality of life, 
predisposes to other diseases and could become persistent through adulthood. This study, the first 
one to assess whether asthma is related to biological aging in children, finds little evidence of 
associations of active wheezing and ever asthma with three different biological ageing markers. 
The overall lack of molecular damage obtained in this study indicate that there is a chance for 
treatment and prevention for asthmatic children at school-age to avoid or diminish damages due 
to asthma related oxidative stress. However, future studies should look at different subtypes of 
asthma (severity, persistence, and age of onset) to confirm our results. 
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